Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

RBC Capital Markets nudges down Alliance Pharma price target

(Sharecast News) - RBC Capital Markets nudged its price target on Alliance Pharma down to 60p from 65p on Wednesday as it said it was rebasing its forecasts as trading normalises.

The bank, which rates Alliance at 'outperform', said it applies 11x price-to-earnings and 6x EV/EBITDA multiples, representing the bottom of the 2025E ranges of global consumer health and UK smid healthcare peers, to its 2026 earnings forecast.

This implies a 12% cost of equity in its discounted cash flow calculation.

RBC cut its 2024 pre-tax profit estimate by around 20%, mostly based on higher operating investments, although it has trimmed revenue forecasts on the basis of the 'above market' guidance provided by the company.

The bank said many of the issues faced by Alliance Pharma in the last 18 months are behind it, and the company now aims to increase marketing investment in its key brands.

"Once the CMA appeal overhang is resolved (we assume imminently), the shares can start better reflecting fundamentals of a growth Consumer Health business, and we see 50% upside to the stock in the first leg of its recovery," it said.

Share this article

Related Sharecast Articles

Billionaire Issa nearing deal to sell Asda stake to TDR Capital - report
(Sharecast News) - US private equity firm TDR Capital is reportedly closing in on a deal to buy petrol station billionaire Zuber Issa's stake in supermarket chain Asda.
Billionaire Issa nearing deal to sell Asda stake to TDR Capital
(Sharecast News) - Private equity firm TDR Capital is reportedly closing in on a deal to buy petrol station billionaire Zuber Issa's stake in supermarket chain Asda.
DS Smith tumbles as Mondi abandons pursuit
(Sharecast News) - DS Smith tanked on Friday after Mondi said it would not be making an offer for the rival packaging group, clearing the path for a takeover by International Paper.
Eqtec agrees amendment to Verde subscription
(Sharecast News) - Waste-to-energy technology developer Eqtec updated the market on the Verde Corporation subscription on Friday, confirming that an amendment to the subscription letter had been agreed upon with Verde.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.